| | | | | | | |
 | JOHNSON & JOHNSON | -0.34% | -1.02% | -12.52% | -13.04% | 4.99% | 432 321 |
| ELI LILLY AND COMPANY | 1.64% | 2.15% | 19.31% | 40.31% | 186.32% | 414 348 |
 | NOVO NORDISK A/S | -1.84% | -2.00% | 14.97% | 40.05% | 148.57% | 355 293 |
| MERCK & CO., INC. | 0.47% | -1.22% | -0.02% | 21.71% | 39.43% | 281 478 |
 | ROCHE HOLDING AG | 0.74% | 0.78% | 0.48% | -9.73% | -12.83% | 257 123 |
| ABBVIE INC. | -3.28% | -3.74% | -17.43% | -8.62% | 47.12% | 235 427 |
 | ASTRAZENECA PLC | -0.62% | 0.24% | 3.39% | 15.15% | 35.78% | 226 503 |
| PFIZER, INC. | 0.00% | -1.58% | -25.80% | -27.40% | 7.22% | 214 635 |
| NOVARTIS AG | 0.65% | -0.55% | 6.03% | 3.54% | 7.31% | 203 244 |
| BRISTOL-MYERS SQUIBB COMPANY | 0.37% | -1.57% | -10.10% | -13.71% | 7.28% | 135 883 |
 | SANOFI | -0.23% | -4.36% | 4.62% | -5.38% | 5.82% | 126 311 |
| AMGEN INC. | -2.89% | -0.30% | -18.42% | -15.45% | -5.57% | 114 490 |
| GILEAD SCIENCES, INC. | -0.95% | -2.67% | -11.23% | 17.66% | 1.40% | 95 061 |
| GSK PLC | 0.36% | -2.67% | -5.93% | -36.17% | -34.45% | 68 386 |
 | DAIICHI SANKYO CO., LTD. | 1.57% | 1.24% | 10.85% | 44.38% | 55.48% | 64 036 |
| | | | | | | |
| | Durchschnitt | -0.29% | -1.15% | -2.79% | 3.55% | 32.92% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.26% | -0.88% | -1.02% | 7.10% | 51.04% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
